Sélectionner une page

Florian STILL

Head of Business Development

Cardiovascular, Inflammation, Neurology, Heart Failure, Rheumatoid Arthritis, Alzheimer

Firalis is a biotechnology company developing diagnostic products based on the discovery, development and regulatory qualification of biomarkers for precision medicine, that improve disease outcome and therapeutic decisions. Firalis develops and markets RUO and IVD kits in the field of cardiovascular diseases (heart failure) neurodegenerative (Alzheimer’s disease), inflammatory and autoimmune (rheumatoid arthritis), through a state-of-the-art technical platform, a team of experts and and a very high quality environment (ISO 9001, ISO 13485, ISO 17025 and NF S 96-900).
Firalis offers a complete range of CRO services including bio-analysis of preclinical and clinical samples to measure biomarkers (ELISA, multiplex and ultra-sensitive immunoassays), Gene expression, Next-Generation Sequencing, Biobanking, Assay Dev.